287 related articles for article (PubMed ID: 7528753)
21. Extracellular matrix synthesized by clonal osteogenic cells is osteoinductive in vivo and in vitro: role of transforming growth factor-beta 1 in osteoblast cell-matrix interaction.
Kirk MD; Kahn AJ
J Bone Miner Res; 1995 Aug; 10(8):1203-8. PubMed ID: 8585424
[TBL] [Abstract][Full Text] [Related]
22. The role of type I collagen in the regulation of the osteoblast phenotype.
Shi S; Kirk M; Kahn AJ
J Bone Miner Res; 1996 Aug; 11(8):1139-45. PubMed ID: 8854250
[TBL] [Abstract][Full Text] [Related]
23. Vgr-1/BMP-6 induces osteoblastic differentiation of pluripotential mesenchymal cells.
Gitelman SE; Kirk M; Ye JQ; Filvaroff EH; Kahn AJ; Derynck R
Cell Growth Differ; 1995 Jul; 6(7):827-36. PubMed ID: 7547504
[TBL] [Abstract][Full Text] [Related]
24. Bone morphogenetic protein-2 facilitates expression of chondrogenic, not osteogenic, phenotype of human intervertebral disc cells.
Kim DJ; Moon SH; Kim H; Kwon UH; Park MS; Han KJ; Hahn SB; Lee HM
Spine (Phila Pa 1976); 2003 Dec; 28(24):2679-84. PubMed ID: 14673369
[TBL] [Abstract][Full Text] [Related]
25. Effect of protein and steroidal osteotropic agents on differentiation and epidermal growth factor-mediated growth of the CFK1 osseous cell line.
Bernier SM; Goltzman D
J Cell Physiol; 1992 Aug; 152(2):317-27. PubMed ID: 1639866
[TBL] [Abstract][Full Text] [Related]
26. Effects of ascorbic acid, calcitriol, and retinoic acid on the differentiation of preosteoblasts.
Choong PF; Martin TJ; Ng KW
J Orthop Res; 1993 Sep; 11(5):638-47. PubMed ID: 8410463
[TBL] [Abstract][Full Text] [Related]
27. Bone morphogenetic protein activities are enhanced by 3',5'-cyclic adenosine monophosphate through suppression of Smad6 expression in osteoprogenitor cells.
Sugama R; Koike T; Imai Y; Nomura-Furuwatari C; Takaoka K
Bone; 2006 Feb; 38(2):206-14. PubMed ID: 16203197
[TBL] [Abstract][Full Text] [Related]
28. Bone matrix mRNA expression in differentiating fetal bovine osteoblasts.
Ibaraki K; Termine JD; Whitson SW; Young MF
J Bone Miner Res; 1992 Jul; 7(7):743-54. PubMed ID: 1642143
[TBL] [Abstract][Full Text] [Related]
29. Dexamethasone, BMP-2, and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: validation of an in vitro model for human bone marrow-derived primary osteoblasts.
Jørgensen NR; Henriksen Z; Sørensen OH; Civitelli R
Steroids; 2004 Apr; 69(4):219-26. PubMed ID: 15183687
[TBL] [Abstract][Full Text] [Related]
30. Cellular and molecular effects of growth hormone and estrogen on human bone cells.
Kassem M
APMIS Suppl; 1997; 71():1-30. PubMed ID: 9357492
[TBL] [Abstract][Full Text] [Related]
31. Different effects of bone morphogenetic proteins 2, 4, 12, and 13 on the expression of cartilage and bone markers in the MC615 chondrocyte cell line.
Valcourt U; Ronzière MC; Winkler P; Rosen V; Herbage D; Mallein-Gerin F
Exp Cell Res; 1999 Sep; 251(2):264-74. PubMed ID: 10471312
[TBL] [Abstract][Full Text] [Related]
32. Bone morphogenetic protein-2 counterregulates interleukin-18 mRNA and protein in MC3T3-E1 mouse osteoblastic cells.
Hori M; Sawai H; Tsuji Y; Okamura H; Koyama K
Connect Tissue Res; 2006; 47(3):124-32. PubMed ID: 16753805
[TBL] [Abstract][Full Text] [Related]
33. Dexamethasone and retinoic acid differentially regulate growth and differentiation in an immortalised human clonal bone marrow stromal cell line with osteoblastic characteristics.
Ogston N; Harrison AJ; Cheung HF; Ashton BA; Hampson G
Steroids; 2002 Oct; 67(11):895-906. PubMed ID: 12234625
[TBL] [Abstract][Full Text] [Related]
34. Parathyroid hormone stimulation and PKA signaling of latent transforming growth factor-beta binding protein-1 (LTBP-1) mRNA expression in osteoblastic cells.
Kwok S; Qin L; Partridge NC; Selvamurugan N
J Cell Biochem; 2005 Aug; 95(5):1002-11. PubMed ID: 15880704
[TBL] [Abstract][Full Text] [Related]
35. Dependence of mesenchymal cell responses on duration of exposure to bone morphogenetic protein-2 in vitro.
Puleo DA
J Cell Physiol; 1997 Oct; 173(1):93-101. PubMed ID: 9326453
[TBL] [Abstract][Full Text] [Related]
36. Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation.
Lee MH; Javed A; Kim HJ; Shin HI; Gutierrez S; Choi JY; Rosen V; Stein JL; van Wijnen AJ; Stein GS; Lian JB; Ryoo HM
J Cell Biochem; 1999 Apr; 73(1):114-25. PubMed ID: 10088730
[TBL] [Abstract][Full Text] [Related]
37. Bone-related growth factors and zoledronic acid regulate the PTHrP/PTH.1 receptor bioregulation systems in MG-63 human osteosarcoma cells.
Tenta R; Sourla A; Lembessis P; Koutsilieris M
Anticancer Res; 2006; 26(1A):283-91. PubMed ID: 16475708
[TBL] [Abstract][Full Text] [Related]
38. Dexamethasone modulates BMP-2 effects on mesenchymal stem cells in vitro.
Jäger M; Fischer J; Dohrn W; Li X; Ayers DC; Czibere A; Prall WC; Lensing-Höhn S; Krauspe R
J Orthop Res; 2008 Nov; 26(11):1440-8. PubMed ID: 18404732
[TBL] [Abstract][Full Text] [Related]
39. Characterization of the stromal osteogenic cell line MN7: mRNA steady-state level of selected osteogenic markers depends on cell density and is influenced by 17 beta-estradiol.
Mathieu E; Merregaert J
J Bone Miner Res; 1994 Feb; 9(2):183-92. PubMed ID: 8140931
[TBL] [Abstract][Full Text] [Related]
40. Bone morphogenetic protein-2b stimulation of growth and osteogenic phenotypes in rat osteoblast-like cells: comparison with TGF-beta 1.
Chen TL; Bates RL; Dudley A; Hammonds RG; Amento EP
J Bone Miner Res; 1991 Dec; 6(12):1387-93. PubMed ID: 1792947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
